Conversations about AI in commercial pharma have largely centered on automation and efficiency gains.
How can we generate content faster? Analyze data faster? Produce insights faster?
These are important advancements, but they focus on individual activities rather than the broader system in which those activities operate. The reality is that most delays in commercial execution don’t occur within a task. The occur between tasks. Every handoff introduces complexity, creates opportunities for misalignment and slows momentum. As commercial organizations face mounting pressure to launch faster, do more with limited resources and respond to rapidly changing market dynamics, accelerating individual tasks is no longer enough. The solution lies in connecting strategy, content, compliance and execution into a coordinated commercialization model that moves work effectively from idea to execution.
This requires a fundamentally different approach to commercial execution.
By orchestrating how work moves across the commercialization lifecycle, organizations can accelerate time to market, respond more quickly to changing market conditions and scale efficiently while maintaining governance.
Automation improves tasks. Orchestration improves outcomes.
The next step is identifying where the greatest opportunities for improvement exist.
Organizations looking to unlock greater speed and scale should consider:
- How long does it actually take to move from strategy to execution?
- Where do approvals and handoffs create unnecessary delays?
- Are we scaling people or scaling processes?
- What would a 50% improvement in speed make possible?
- How can we move faster without increasing risk?
The answers often reveal opportunities with meaningful business impact. A 50% improvement in speed means more than faster campaigns. It means reaching healthcare professionals sooner, responding more quickly to market dynamics, bringing innovations to patients faster and creating capacity for teams to focus on higher-value work. The ability to move faster without increasing risk comes from embedding governance, compliance and human oversight throughout the process, not adding it at the end.
So What Does Orchestration Look Like In Practice?
Watch the video below to see how strategy, content, compliance and execution can work together as part of a coordinated commercialization model.
Proof That Orchestration Delivers Results
The benefits of orchestration are not theoretical. The real value emerges when the commercialization process is connected from end to end.
Google Cloud recently showcased EVERSANA’s AI Agency Platform and the measurable outcomes achieved through its coordinated, AI-powered operating model. Campaign development timelines were reduced from months to weeks, project delivery accelerated by 50%, project costs decreased by 30% and approval-ready campaign content could be developed in approximately 30 minutes.
These outcomes demonstrate what becomes possible when commercialization is approached as a connected process rather than a series of disconnected activities.
What Would 50% Improvement in Delivery Speed Mean for Your Organization?
See how Google Cloud documented EVERSANA’s approach.
Read The Case Study
The next frontier isn’t automation. It’s orchestration across the entire commercialization lifecycle.
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…